Clare Ozawa is a Versant Ventures managing director who combines a Stanford Ph.D. with hands-on operational experience as former COO and Chief Business Officer at Inception Sciences, Versant's discovery engine for seeding new biotechs. She leads investments in San Diego and the Bay Area while serving on boards of therapeutic platform companies including Capsida, Lycia, Gate Bioscience, and 858 Therapeutics. Clare Ozawa is a Versant Ventures managing director who combines a Stanford Ph.D. with hands-on operational experience as former COO and Chief Business Officer at Inception Sciences, Versant's discovery engine for seeding new biotechs. She leads investments in San Diego and the Bay Area while serving on boards of therapeutic platform companies including Capsida, Lycia, Gate Bioscience, and 858 Therapeutics.